Spike Protein Gain of Function: Why mRNA Injections Aren't Vaccines | Dr. Typhaine Pinsolle

Dr. Typhaine Pinsolle breaks down the Spike protein's engineered structure with HIV inserts, furin cleavage site, SV40 promoters, and why COVID mRNA injections don't meet the definition of a vaccine.

TL;DR (1-minute read)

TL;DR

• Spike protein is engineered: Created through Gain of Function with 4 major modifications for human transmission
• Structure contains HIV inserts: 3 Gp120 inserts from HIV enable binding to human ACE2 receptors
• Furin Cleavage Site: Unique to SARS-CoV-2, splits Spike into S1 (amyloid/neuroinflammatory) and S2 (fusogenic)
• mRNA Spike vs viral Spike: 3 critical differences. Amino acid substitutions, different glycosylation, N-methyl-pseudouridines (carcinogenic)
• mRNA injections aren't vaccines: They make your body produce the toxic Spike protein in unknown quantities for unknown duration
• Lipid Nanoparticles (LNPs): Cross blood-brain barrier and placenta. Moderna patented their use in 2012
• SV40 promoter: Found in Pfizer mRNA injections. Enables nuclear entry and potential genome integration
• Biological weapons evidence: Congressional hearings, Prof. Boyle's affidavit, DARPA funding, military involvement
• No dose control: Unlike real vaccines, genetic injections have no known or controllable dose

What Is the Spike Protein?

The Spike protein is a surface protein present naturally in several viruses, including coronaviruses. But SARS-CoV-2's Spike is different. It was manufactured through Gain of Function (GoF) research. That means it's not a natural protein.

Figure 1: Structure of SARS-CoV-2 showing the Spike protein highlighted on the viral surface. The Spike protein is a surface protein naturally present in coronaviruses, but SARS-CoV-2's version was manufactured through Gain of Function research with 4 major modifications: enables human transmission, increases pathogenicity, allows persistence in the organism, and creates unprecedented biological functions. Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

GoF introduced 4 major modifications:

1. Transmission: Enables a virus of animal origin to infect humans
2. Increased pathogenicity: Potentially makes the virus more dangerous
3. Persistence: Allows the virus to remain in the organism longer
4. Unprecedented functions: Creates biological capabilities not seen in nature

This isn't random evolution. It's engineering.

Spike Structure: Engineered to Infect Humans

The Spike protein is composed of 3 identical units. Here's what makes it dangerous: Figure 1a: Detailed molecular model of the SARS-CoV-2 Spike protein showing the 3 identical units. Red arrows indicate the 3 Gp120 inserts from HIV that enable binding to human ACE2 receptors. Green arrow shows the Furin Cleavage Site unique to SARS-CoV-2. Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

HIV Inserts

Three Gp120 inserts from HIV are perfectly adapted to bind to human ACE2 receptors. That's why the virus infects humans so effectively. Without these inserts, zoonotic transmission (animal-to-human) wouldn't work this efficiently.

Scientific Evidence: This observation builds on a January 2020 bioRxiv preprint by Pradhan et al. that identified four short amino-acid insertions in the SARS-CoV-2 spike glycoprotein absent from other coronaviruses, with sequence identity to segments of HIV-1 gp120 (V4, V5, V1 domains) and Gag protein. The authors calculated low probability of chance occurrence and noted similar isoelectric points (pI ≈ 10 ± 2).

Supporting Research:

• Pradhan et al., bioRxiv (2020) - "Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag" (DOI: 10.1101/2020.01.30.927871) - Four inserts mapped to HIV-1 gp120 residues (404–409, 462–467, 136–150) and Gag (366–384)
• Perez & Montagnier, Int J Res (2020) - Discusses exogenous informative elements including possible HIV-related sequences in spike region
• Fantini et al., Int J Mol Sci (2023) - Explores structural/electrostatic similarities between SARS-CoV-2 spike and HIV-1 gp120

Limitations & Scientific Context: The Pradhan preprint was withdrawn shortly after posting. Critics (Zhang et al., 2020) argued the inserts were not truly unique, occurred in variable regions, and reflected convergent evolution rather than engineering. No wet-lab evidence of intentional insertion has been published. This remains a contested hypothesis within the scientific community.

Furin Cleavage Site (FCS)

The FCS is present only in SARS-CoV-2. No other coronavirus has it. This site allows the Spike to split into two subunits: S1 subunit:

• Amyloid formation
• Neuroinflammatory effects S2 subunit:
• Fusogenic (fusion with cells)

The Translation: The Spike isn't just a key that activates cells. It's a bioweapon with two separate attack mechanisms. One for your brain, one for cell fusion.

Direct Evidence of FCS Engineering: The deliberate nature of FCS insertion as a GoF technique is confirmed by the 2025 discovery of Zhengli Shi's MERS Gain-of-Function chimera (HKU4r-HZAU-2020) in pre-pandemic Wuhan rice sequencing datasets. This chimera contained a deliberately inserted MERS spike with both a furin cleavage site (PRSVR motif) and human endothelial cell protease site (AFNH).

Figure 1b: MERS-CoV spike protein showing engineered furin cleavage site (PRSVR) and human endothelial cell protease site (AFNH), both highlighted in red. These features were deliberately inserted into HKU4 backbone using Shi's pBAC-CMV infectious clone system, demonstrating that FCS insertion was an active research technique in Wuhan immediately prior to the pandemic. Source: Massey et al., Journal of Bioinformatics and Systems Biology (2024); Steven E. Massey Zenodo preprint (13 Dec 2025)

Key Points:

• FCS at S1/S2 enables efficient human airway protease activation
• hECP site enhances endothelial cell tropism
• Combined effect: Significantly enhanced human infectivity
• Constructed using Shi's pBAC-CMV system (Zeng et al. 2016)
• Funded by NIAID R01AI110964 (Daszak/Shi)

Figure 1c: NIAID grant R01AI110964 "Understanding the Risk of Bat Coronavirus Emergence" with Peter Daszak (PI) and Zhengli Shi (Co-PI), demonstrating US taxpayer funding for the exact GoF research that produced FCS insertion technology used in the MERS chimera. Source: Hensel preprint analysis, NIH RePORTER

How Proteins Are Made (The mRNA Injection Mechanism)

Your cells produce proteins through two steps:

1. Transcription DNA (genes) gets transcribed into mRNA 2. Translation The mRNA gets translated into proteins. These are specific sequences of amino acids.

Each protein has a biological function, like a key opening a lock. The Spike of SARS-CoV-2 is the key that allows viral entry.

How SARS-CoV-2 Infects Cells

SARS-CoV-2 is an obligate cellular parasite. It needs your cellular machinery to multiply:

Figure 3: Mechanisms of infection by SARS-CoV-2. Like all viruses, SARS-CoV-2 is an obligate cellular parasite requiring the cell's machinery to multiply. The Spike (key) binds to ACE2 receptor (lock), virus fuses and penetrates, viral mRNA is released and translated by cell tools to produce viral proteins (N, S, M, E), virions assemble, then cell explodes releasing virions to infect other cells. Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

1. Spike (key) binds to ACE2 receptor (lock)
2. Virus fuses and penetrates the target cell
3. Viral mRNA is released
4. Your cell's tools translate the viral mRNA to produce viral proteins (N, S, M, E)
5. Viral proteins assemble into new virions
6. Cell explodes, releasing virions to infect other cells

The "Vaccine" Bait and Switch

Following infection, your cells produce Spike. That's expected.

But following mRNA or DNA injections, your cells also produce Spike. These injections work the same way. They force your body to manufacture the antigen.

The problem: These products were wrongly called "vaccines."

Why? Because they don't meet the definition.

What Is a Vaccine? (Actual Definition)

The aim of a vaccine: Use material harmless to the organism to mimic pathogen infection. This allows immune defense development (antibodies), inducing lasting protection against future encounters and preventing illness.

How real vaccines work:

• Inject attenuated or inactivated pathogen
• Or inject purified antigen from that pathogen
• Known quantity = known dose Key point: Vaccines are prophylaxis (prevention), not curative treatment.

They Changed the Definition Instead of Fixing the Product

In September 2021, the CDC and Merriam-Webster updated their definitions of vaccine and vaccination.

Old CDC definition (before Sept 2021): A product that stimulates a person's immune system to produce immunity to a specific disease, protecting the person from that disease.

New CDC definition (Sept 2021): A preparation that is used to stimulate the body's immune response against diseases.

What changed: Immunity became protection Protecting the person from that disease was removed entirely

The CDC's excuse: They claimed the change was for transparency and technical accuracy to avoid implying vaccines are 100% effective.

The reality: They moved the goalposts. When your product doesn't meet the definition, you change the definition.

This definition was changed to accommodate products that:

• Don't provide lasting immunity
• Don't prevent infection
• Don't prevent transmission
• Require endless boosters

The word vaccine used to mean something specific. Now it means whatever they need it to mean.

Why mRNA Injections Aren't Vaccines

mRNA injections work by injecting genetic code (DNA or RNA) that makes your body produce the antigen. That antigen is the Spike protein. Three problems:

1. We don't know which cells produce Spike
2. We don't know the quantity produced
3. We don't know how long production continues These are genetic injections, not vaccines. The biological reality: In natural infection, the Spike protein doesn't produce the most antibodies or the most lasting ones. Basing supposedly protective injections on this single toxic protein was nonsense.

   Aspect	Traditional Vaccine	mRNA Genetic Injection
   What is delivered	Known amount of antigen or weakened pathogen	Genetic instructions to produce Spike
   Dose & duration	Precise and transient	Unknown quantity & unknown duration
   Production location	Outside the body or controlled	Inside your own cells (anywhere LNPs reach)
   Immune outcome	Typically protective	Can drive IgG4 shift & tolerance (see 2026 article)
   Manufacturing risk	Standard	High bacterial DNA/SV40 contamination (Process 2)
   Definition fit	Matches classical criteria	Required CDC definition change in 2021

Table 1: Core differences showing why mRNA products do not meet traditional vaccine standards (updated March 2026).

Viral Spike vs mRNA Spike: What's Different?

Nearly identical. But there are 3 critical exceptions:

1. Amino Acid Substitutions (2P Proline Stabilization)

The mRNA-coded Spike has 2 amino-acid substitutions (K986P and V987P) that stabilize the prefusion conformation. These "2P" substitutions lock the Spike in its prefusion state to make it a more effective antigen. Figure 4a: S-2P (K986P/V987P) proline substitutions in mRNA vaccine spike. Panel A shows amino acids KY at positions 986-987 in native SARS-CoV-2 spike replaced by PP in the S-2P variant used in Pfizer/BioNTech and Moderna vaccines. Panel B shows partial structure from PDB 6VSB with the two proline residues stabilizing the structural bend between HR1 and central helix. These substitutions prevent transition from prefusion to postfusion conformation, locking spike in its prefusion state. Source: Xia X. Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design, Viruses 2021, 13(1): 109

Figure 4a-1: PDB 6VSB crystal structure of the 2P-stabilized SARS-CoV-2 spike prefusion conformation. The two proline mutations (K986P and V987P) are highlighted in red, showing their position at the hinge region between the heptad repeat 1 (HR1) and central helix. These engineered substitutions lock the spike in its prefusion state by preventing the conformational transition required for membrane fusion. This structural modification is present in both Pfizer/BioNTech and Moderna mRNA vaccine sequences. Source: Wrapp D. et al., Science 2020;368(6493):1189-1193, PDB 6VSB

2. Different Glycosylation

The mRNA Spike has different sugar molecules attached, affecting how it interacts with cells.

3. N-methyl-pseudouridines

The mRNA uses N1-methyl-pseudouridine instead of natural uridine throughout the entire sequence. Figure 4b: Chemical structures of natural RNA bases vs synthetic mRNA modifications. Shows uridine (natural), pseudouridine (Ψ - isomerized uridine), and N1-methyl-pseudouridine (m1Ψ - the modification used in COVID vaccines and other mRNA therapeutics). The key difference: m1Ψ has a methyl group at the N1 position (red highlight) that eliminates a hydrogen bond donor, enabling immune evasion and enhanced translation. This molecular change is what causes the +1 ribosomal frameshifting documented by Mulroney et al. (Nature 2023). Source: RSC Chemical Biology 2024, doi:10.1039/d4cb00022f

Figure 4b-1: Detailed chemical structure comparison showing the isomerization from uridine to pseudouridine creates an extra hydrogen bond donor (N1H), and N1-methylation eliminates this donor while maintaining the C-C bond that enables nucleobase rotation. Supplementary diagram providing additional molecular detail. Source: Morais et al., Frontiers in Cell and Developmental Biology 9, 789427 (2021) - Figure 1 Figure 4c: Schematic comparison of unmodified mRNA vaccines (CureVac CVnCoV, ~48% efficacy) vs N1-methyl-pseudouridine modified mRNA vaccines (Pfizer/Moderna, >90% efficacy). The modified version evades immune detection while enhancing protein production. Source: Morais et al., Frontiers in Cell and Developmental Biology 9, 789427 (2021) - Figure 2 What N1-methyl-pseudouridine does:

• Evades innate immune sensors (TLR3, TLR7, TLR8, PKR)
• Increases translation efficiency and ribosome loading
• Causes ribosome pausing and altered translation dynamics
• Potential for amino acid substitutions during protein synthesis
• Unknown long-term consequences from widespread cellular use

What stays the same:

• Furin cleavage site is conserved → S1/S2 dissociation still happens
• Same ACE2 interaction → still infects human cells

Bottom line: The mRNA Spike is engineered differently with potentially MORE dangerous properties than the natural viral Spike. The 2P substitutions lock it in prefusion state, while N1-methyl-pseudouridine modifications cloak it from immune detection and alter protein synthesis in ways we don't fully understand.

Lipid Nanoparticles (LNPs): The Delivery System

LNPs carry the mRNA code. They're another problematic component:

Figure 5a: Overall schematic of lipid nanoparticle structure and mechanism for RNA therapeutic delivery. LNPs encapsulate mRNA, protect it from degradation, facilitate cellular uptake, and enable endosomal escape. Source: ResearchGate - Overall schematic illustration of lipid nanoparticles for delivery of RNA therapeutics

Figure 5b: Detailed schematic of LNP design for mRNA delivery, showing chemical structure and composition of ionizable lipids, PEG-lipids, cholesterol, and helper lipids. Source: ResearchGate - Schematic illustration of the design of LNPs for mRNA delivery

Figure 5c: Biodistribution of Lipid Nanoparticles (LNPs). The modified mRNA sequence coding for Spike protein is encapsulated in LNPs (fats) for protection because mRNA is fragile. These LNPs have demonstrated inflammatory properties, improve distribution and cellular integration, are not vectorized (can reach all cells), and cross essential biological barriers including the blood-brain barrier and placenta. Moderna patented this formulation in 2012 (WO2012045075 A1, European patent EP11830061). Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

What they do: The modified mRNA sequence coding for the Spike protein must be protected because mRNA is fragile. For this, it has been encapsulated in lipid nanoparticles (LNPs), or fats. Yet it has been demonstrated that these LNPs have inflammatory properties. These LNPs improve distribution in the organism and cellular integration. They are not vectorized and can therefore address all the cells of the body. Worse still, they allow the crossing of essential biological barriers that defend certain body compartments, such as the blood-brain barrier (which protects the brain) or the placenta (which protects the fetus). Endosomal membrane damage: LNPs cause endosomal membrane damage, contributing to:

• Neurodegenerative disease, including Alzheimer
• Cancer progression
• Exploitation by pathogens to enhance infectivity
• NEW 2024: Spike-induced MMP-9 release – SARS-CoV-2 Spike protein stimulates human microglia to release matrix metalloproteinase-9 (MMP-9), elevated in Long COVID patients; MMP-9 degrades tight junction proteins, directly contributing to blood-brain barrier breakdown (PMID: 39403255) Sources:
• https://doi.org/10.1101/2024.04.16.589801
• https://link.springer.com/article/10.1186/s40035-024-00460-7
• https://link.springer.com/article/10.1007/s10555-020-09870-1
• https://link.springer.com/chapter/10.1007/978-0-387-39951-5_11 Moderna patent:
• International patent WO2012045075 A1 (2012)
• European patent EP11830061, registered the same year
• European Patent Register: https://register.epo.org/application?number=EP11830061

LNPs don't stay at the injection site. They distribute systemically. That means Spike production can happen anywhere. Including your brain and a developing fetus.

Developmental neurotoxicity concerns:

• NEW 2023: Prenatal Spike exposure – Studies in male neonatal rats show prenatal SARS-CoV-2 Spike protein exposure induces gliosis, neuronal death in hippocampal CA1-CA3 and cerebellum, plus autism-like neurobehavioral changes (PMID: 37889404)
• UCSF 2022: HAND diagnostic criteria met – In post-COVID patients with cognitive symptoms, 59% met formal HIV-associated neurocognitive disorder (HAND) diagnostic criteria using the same neuropsychological battery as in HIV clinics
• These findings demonstrate Spike's neurodevelopmental risks extend beyond adult neurotoxicity to fetal brain development and pediatric cognitive impairment

SV40 Promoter: The Nuclear Key

Pfizer's mRNA injections contain something else problematic: SV40 promoter sequences.

Figure 6: SV40 promoter sequence found in Pfizer mRNA injections. SV40 (Simian Virus 40) is a virus known to cause cancer in animal models. The promoter sequence acts as a nuclear localization signal, helping mRNA enter the cell nucleus and enabling potential integration into human DNA, which would turn cells into permanent Spike protein factories. Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

What is SV40? Simian Virus 40. A virus known to cause cancer in animal models. What does the promoter do?

• Acts as a nuclear localization signal (NLS)
• The SV40 NLS sequence is PKKKRKV a cluster of basic amino acids that bind nuclear import machinery
• Helps mRNA enter the cell nucleus via nuclear pore complexes
• Multiple NLS sequences enhance nuclear transport efficiency
• Enables potential integration into human DNA

How SV40 Nuclear Localization Signals Work:

The SV40 NLS from the large T antigen is one of the most well-characterized nuclear localization signals. It functions by binding to importin-α, which then recruits importin-β to transport the cargo through the nuclear pore complex. The presence of this sequence in Pfizer mRNA injections means the lipid nanoparticles (LNPs) and their mRNA payload can be actively transported into the nucleus not just remain in the cytoplasm where conventional vaccines operate.

Why this matters: If mRNA integrates into your genome, your cells become permanent Spike factories. This isn't temporary. This isn't what vaccines do. Manufacturing Context: The SV40 promoter contamination stems from the switch to Process 2 manufacturing, which uses E. coli plasmid DNA templates instead of enzymatic methods. This cost-cutting change introduced bacterial DNA with active viral promoters that were never present in the clinical trial vaccine. For the full manufacturing evidence and process comparison, see: The Case for Halting mRNA Experiments. Figure 6b: mRNA vaccine manufacturing process flowchart. The key contamination risk point is the plasmid DNA template preparation. When E. coli bacteria are used to amplify plasmid DNA (Process 2), residual bacterial DNA containing SV40 promoter sequences can contaminate the final mRNA product. The linearization step (ring-opening of circular plasmids) and subsequent DNase treatment are often incomplete, leaving RNA:DNA hybrids and DNA fragments that get packaged into lipid nanoparticles along with the mRNA. Source: Process and analytical strategies for the safe production of mRNA vaccines and therapeutics, PMC12819531

Spike Persistence After mRNA Injections – 2025–2026 Evidence

The original presentation correctly highlighted the lack of any "off switch" for Spike production. Independent studies since March 2025 have confirmed this is a real and widespread issue:

• Spike or S1 subunit remains detectable in blood, monocytes, or tissues for months to over 700 days in multiple cohorts
• Vaccine-derived Spike has been found accumulated at the skull–meninges–brain axis and in cerebral arteries
• Landmark 2022 Nature study (Stein et al.): SARS-CoV-2 RNA and protein detected in basal ganglia and other CNS sites up to 230 days post-infection in autopsy cohort (N=44) – demonstrating the Spike protein's ability to persist deep in brain tissue
• In some individuals, production appears semi-permanent due to possible nuclear effects of the SV40 promoter discussed above

Specific Quantification Studies:

Short-term persistence (days to weeks):

• Krauson et al., npj Vaccines (2023) - Vaccine mRNA detected in axillary lymph nodes up to 30 days; spike protein found in myocardium of subset of patients dying within 30 days post-vaccination

Medium-term persistence (months):

• Ota et al. (2025) - Spike protein expression in cerebral arteries up to 17 months post-vaccination (female predominance noted)
• Patterson et al. (2025) - S1 subunit persists in CD16+ monocytes up to 245 days in post-vaccine syndrome cases
• Circulating recombinant spike protein fragments appear in blood for 187–709 days in systematic analyses

Long-term persistence (years):

• Zenodo case report (2026) - Free Wuhan spike protein detected at 1,173 days post-vaccination (129 fg/mL plasma); vaccine mRNA in exosomes at 1,284 days; persistent spike in skin biopsies (endothelial cells, macrophages, nerve fibers) at 1,364 days, with plasmid DNA (spike gene + SV40 enhancer) confirmed by PCR/Sanger sequencing

Government Safety Surveillance Confirms Stroke Risk: HHS documents released by Senator Ron Johnson (March 2026) show a statistically significant ischemic stroke signal in adults 65+ receiving Pfizer bivalent boosters that persisted from 2022 through 2025 across multiple surveillance systems (VSD, VAERS). Internal communications reveal officials downplayed the risk by editing "moderately elevated" to "slightly elevated," with no public warnings issued—demonstrating that government monitoring systems are detecting the very risks predicted by Spike protein toxicity research.

Scientific Context: These findings indicate prolonged antigenic exposure in subsets of individuals, with potential implications for cumulative dose-dependent effects including:

• Endothelial dysfunction (circulating S1 disrupts endothelial function via ACE2 downregulation - Lei et al., Circ Res 2021)
• Immune modulation (IgG4 class switching with ongoing stimulation)
• Systemic spread via monocytes and exosomes
• Possible prion-like or amyloidogenic effects

Note: Most studies are small or case-based; detection does not prove causation of pathology. Regulatory agencies assert spike clears within weeks, but these data directly challenge that narrative and support arguments for cumulative dose-dependent effects.

These findings turn the theoretical "unknown duration" into documented prolonged exposure – far beyond any classical vaccine. For the full picture on contamination that enables this persistence, see the follow-up article: The Case for Halting mRNA Experiments.

Dr. Meryl Nass Confirms: Not Vaccines

Dr. Meryl Nass, internist and researcher, testified before Congress: Her conclusions:

• These injections are not vaccines
• LNPs are problematic
• mRNA technology gives unknown dose, duration, and cells producing Spike
• Injections based on the most toxic (not most immunogenic) protein
• Several viral proteins are synthetic and designed to harm the immune system

Her statement:

"I think this virus was made in a biological weapons laboratory. It was designed to be particularly toxic."

Are These Biological Weapons?

German Intelligence Assessment: 80-95% Lab Origin Probability

In March 2025, Swiss newspaper NZZ reported that Germany's Federal Intelligence Service (BND) assessed SARS-CoV-2 as having an 80-95% probability of laboratory origin under Operation "Saaremaa." This assessment was based on public-domain evidence including the MERS-related chimera discovery and explicitly cited safety violations at Wuhan laboratories.

Key Findings:

• Initial BND assessment (2020): Low probability of lab origin
• Updated assessment (2025): 80-95% probability based on accumulated evidence
• Operation "Saaremaa" investigated Wuhan lab safety violations
• Cited the MERS clone discovery as supporting evidence for ongoing GoF work
• Findings withheld from public during pandemic

Media Reports:

• NZZ (Neue Zürcher Zeitung) - Initial report on German government assessment
• Süddeutsche Zeitung - BND 80-95% probability details
• Zeit - Operation Saaremaa investigation
• Deutsche Welle - Confirmation of lab mishap assessment

International Context: The BND assessment adds to multiple allied intelligence agencies (US, UK, France) that independently suspected lab origin in 2020, with the MERS clone discovery specifically cited as supporting evidence for ongoing GoF work.

Sources: NZZ (12 Mar 2025); Süddeutsche Zeitung; Zeit via archive.is; DW report on BND assessment; Massey et al. (2024) Journal of Bioinformatics and Systems Biology

Huanan Market Data Integrity: The Missing Evidence

The zoonotic origin narrative centers on the Huanan Seafood Market as the spillover site. However, forensic analysis of the genomic data reveals critical gaps and inconsistencies that undermine this theory.

The Core Problem: Missing Critical Samples

Despite collecting over 900 environmental samples from the Huanan market in early 2020, key evidence necessary to prove or disprove market origin remains unavailable:

1. No animal genomes published: Not a single complete genome from any potential intermediate host animal collected at the market has been released
2. No viral sequences from animals: Zero SARS-CoV-2 sequences isolated from market animals have been made public
3. Incomplete human metadata: Clinical epidemiological data linking early cases to specific market locations is fragmented

Data Accession Irregularities:

• Genomic data uploads to GISAID/NCBI show inconsistent accession dates and metadata
• Critical sequences appeared months after initial collection, with chain-of-custody documentation incomplete
• Some early case sequences lack precise exposure histories despite being collected for market origin analysis

The Raccoon Dog Mitochondrial DNA Issue:

Reports of raccoon dog mitochondrial DNA co-located with SARS-CoV-2 genetic material in market swabs were cited as evidence of infected animals. However:

• Mitochondrial DNA alone cannot prove active infection
• No raccoon dog tissue samples with viral isolates were produced
• The presence of environmental DNA from susceptible species does not establish spillover mechanism
• This finding has been mischaracterized in media as proving animal-to-human transmission

NOASH Recommendations Ignored:

The National Outbreak Analytics Steering Subcommittee (NOASH) issued recommendations for investigating pandemic origins, including:

• Full disclosure of all raw sequencing data with complete metadata
• Independent access to all environmental and clinical samples
• Transparent documentation of collection dates, locations, and chain of custody
• Unrestricted analysis of all potential intermediate host species

These recommendations have not been followed for Huanan market samples.

The Forensic Implication:

Without complete animal genomes from the market, without viral isolates from market animals, and with inconsistent data management practices, the market-origin theory rests on circumstantial evidence that cannot be independently verified.

This data opacity contrasts sharply with the extensive documentation of GoF research activities at Wuhan laboratories, including the MERS chimera construction using Shi's pBAC-CMV system (see Figure 1b). When intelligence agencies assess 80-95% probability of lab origin, they are weighing documented GoF capabilities against incomplete market data that cannot definitively establish natural spillover.

The Statistical Flaw in "Multiple Introductions" Claims

Mainstream market-origin arguments (Pekar et al. 2022, Science; Worobey et al. 2022, Science) rely heavily on phylogenetic analyses claiming multiple independent SARS-CoV-2 introductions at the Huanan market. However, this "multiple introductions" signal has been shown to be a statistical artifact.

The Core Problem: Imbalanced Hypothesis Testing

McCowan (2025, arXiv2502.20076) demonstrates that the framework used to claim multiple zoonotic spillovers is mathematically biased:

The Bias Direction:

The hypothesis testing framework compares:

• H₀ (null): All lineages trace to a single transmission source
• H₁ (alternative): Lineages trace to different sources

When H₀ is rejected, authors conclude "multiple zoonotic introductions." However, McCowan shows:

• H₀ is formulated so strictly that it's nearly impossible to satisfy even under genuine single-origin scenarios
• H₁ accepts "multiple sources" without requiring evidence that those sources were zoonotic
• Lab-origin scenarios are rejected by design, not by evidence

What This Means:

"The purported quantitative support for multiple zoonotic introductions is an artefact of an imbalanced hypothesis testing framework that favors zoonotic conclusions." — McCowan (2025)

The lineage A and B split claimed to represent independent market spillovers cannot be statistically distinguished from a single introduction with realistic sampling biases.

Sampling Bias Confirmed:

Early SARS-CoV-2 sequencing in Wuhan was not epidemiologically representative:

• Researchers prioritized cases with known market exposure
• Community cases without market links were undersampled
• This creates artificial phylogenetic clustering that mimics "multiple introductions"

The Implication:

If the "multiple introductions" claim is statistically invalid, the market epicenter hypothesis loses its primary quantitative support. The apparent pattern of diversity at Huanan is consistent with:

• Single introduction from any source (lab or market)
• Sampling bias toward market-linked cases
• No requirement for multiple zoonotic spillover events

Sources:

• McCowan A. (2025). "Purported quantitative support for multiple introductions of SARS-CoV-2 into humans is an artefact of an imbalanced hypothesis testing framework." arXiv2502.20076. https://arxiv.org/abs/2502.20076
• Supporting analysis: Weissman M. (2024). "Science's Pekar et al. 2022 is wrong." Substack. https://michaelweissman.substack.com/p/sciences-pekar-et-al-2022-is-wrong

Figure 7: Professor Francis Boyle's affidavit (May 27, 2024) confirms both the SARS-CoV-2 virus and the mRNA injections meet the legal definition of biological weapons and weapons of mass destruction. Boyle drafted the U.S. Biological Weapons Anti-Terrorism Act of 1989. Source: Dr. Typhaine Pinsolle, COVID mRNA Vaccine Analysis Presentation, August 15, 2024

The evidence suggests yes.

Congressional Hearings

U.S. Congressional and Senate hearings since May 2021 investigated virus origin and GoF funding using FOIA requests. These bipartisan hearings revealed:

• Major corruption and cover-ups by government agencies
• GoF funding at Wuhan Institute
• Lies under oath by key officials
• Involvement of multiple countries

Key witnesses:

• Dr. Peter Daszak (EcoHealth)
• Dr. Anthony Fauci (NIAID)
• Dr. David Morens

Senator Rand Paul hearings:

• 4 scientists testified
• Revealed obstruction of lab-origin papers
• Dangerous GoF research exposed
• Proposal for new oversight law (rejected for now)

Prof. Francis Boyle's Affidavit

Prof. Francis Boyle's affidavit (May 27, 2024): Both the virus and the mRNA injections meet the legal definition of:

• Biological weapons
• Weapons of mass destruction Boyle's credentials:
• Drafted the U.S. Biological Weapons Anti-Terrorism Act of 1989
• Expert in biological weapons law
• Professor of international law

His findings:

• DARPA (Pentagon) funded Moderna mRNA technology
• Fort Detrick was involved
• Both virus and vaccines are biological weapons
• This meets the legal definition of WMDs

Specific Biological Weapons Convention Violations:

Boyle's assessment is based on violations of the Biological Weapons Convention (BWC), which entered into force in 1975. The specific articles implicated include:

Article I - Prohibited Agents:

"Each State Party... undertakes not to develop, produce, stockpile or otherwise acquire or retain: (1) Microbial or other biological agents... which have no justification for prophylactic, protective or other peaceful purposes..."

The chimeric MERS-HKU4 work (NIAID R01AI110964, Daszak/Shi) and unreported GoF on merbecoviruses lack clear defensive justification. The pBAC-CMV infectious clone system with FCS insertion and hECP enhancement has no prophylactic purpose beyond creating enhanced human pathogens.

Article III - Transfer Prohibition:

"Prohibition on transfer or assistance..."

NIAID R01AI110964 funding to EcoHealth Alliance, subcontracted to Wuhan Institute of Virology, constitutes technical assistance for dual-use GoF research. This includes:

• Technology transfer for pBAC-CMV infectious clone system
• Training in advanced coronavirus engineering methods
• Funding for FCS and hECP insertion research
• Support for chimeric virus construction

Article IV - National Measures:

"Requires national measures to prohibit and prevent development/production within a state's territory"

U.S. government funding (NIAID, DARPA) for GoF coronavirus research at WIV violated obligations to prevent development of biological weapons agents on U.S. territory or through U.S. funding abroad.

Supporting Sources:

• Skopec R. "Coronavirus is a Biological Warfare Weapon." J Vaccines Vaccin 2021;12:446 - Open-access review summarizing Boyle's position
• BWC Full Text (1972) - UNODA archives
• Massey SE et al. Zenodo (2025) - "Potential violation of the Biological Weapons Convention" with pBAC-CMV chimeric infectious clone evidence

Context: These violations are interpretive—no formal BWC complaint has succeeded. Counter-arguments emphasize legitimate vaccine/countermeasure research. However, the NIAID R01AI110964 grant (Daszak PI, Shi Co-PI) funded the exact pBAC-CMV system used to construct the MERS chimera, creating a documented funding trail from U.S. taxpayers to GoF research with no clear peaceful application.

U.S. Military Involvement

Figure 8: Comprehensive diagram showing the web of connections between U.S. agencies (NIH/NIAID, DARPA, Department of Defense), research organizations (EcoHealth Alliance, Moderna), international partners (Wuhan Institute, France), and funding sources involved in Gain of Function research that led to SARS-CoV-2. Originally published by BAM! in June 2024.

The connection web:

• NIH/NIAID funded GoF research
• EcoHealth funneled money to Wuhan
• Moderna received DARPA funding
• Military involvement at multiple levels
• Multiple countries involved
• No one spends millions on a "cold" without return on investment

The reality: GoF research = disguised biological weapons research, funded by U.S. intelligence/military. Proof of U.S. funding bio-research in Ukraine since 2005:

• Including Metabiota
• Hunter Biden connections
• Treaty evidence available

The Spike Protein Is the Biological Weapon

Common to virus and injections:

The Spike protein is the most toxic protein, responsible for:

• Vascular damage
• Cardiotoxicity
• Neurotoxicity
• Autoimmunity
• Cancer reactivation
• Amyloid/prion-like diseases
• And more... U.S. Patent Modified polynucleotides for oncology-related proteins (Moderna): Figure 9: Moderna patent US-9587003-B2, filed in 2012 and granted in 2016. The patent document shows multiple biological activities explained by the furin cleavage site, demonstrating intent and foreknowledge of the Spike protein's engineered properties years before COVID-19. Sources: PubChem and Daily Mail
• 2016 patent (filed 2012)
• Shows multiple activities explained by the furin cleavage site
• Demonstrates intent and foreknowledge

The Bottom Line

What the evidence shows:

• Patent timeline demonstrates intent
• Virus + injections = military biological weapons (fragmentation + delayed effect)
• U.S. military involvement and cover-ups
• Multiple countries involved
• No one spends millions on a "cold" without return on investment

Many "emerging" pathogens raise the same questions:

• HIV
• Bird flu
• Zika
• Ebola
• Lyme disease

The biggest trauma: Governments may not have our best interests at heart. We must inform ourselves, organize, and collectively resist.

This is about the survival of humanity.

Dr. Pinsolle's Assessment

When asked about the mechanism and regulatory pathway, Dr. Pinsolle observed:

"Therapia, in Greek, means 'care.'

"There's no notion of care in these injections."

The regulatory gap

These injections should have been evaluated as gene therapies based on mechanism of action. Gene therapy aims to repair or replace a defective gene. The billions injected didn't have defective genes.

They took advantage of a gap. These products were neither vaccines nor gene therapies, so they avoided the evaluation standards that either category would require.

What proper evaluation requires

Gene therapy frameworks exist for a reason. Delivering genetic material to cells to produce a protein requires:

• Long-term safety monitoring, not 2-month trials
• Biodistribution studies, where does the mRNA go
• Persistence investigation, how long does production continue
• Integration risk assessment, can SV40 promoters enable genome integration

What happened instead

• Shortened EUA trials
• No biodistribution data before rollout
• Assumed spike clears within weeks, now proven false up to 1,173 days
• Ignored SV40 promoter nuclear localization signals
• Changed the definition of vaccine to fit the product

The Greek word therapia means care, the fundamental principle of medicine. These injections bypassed the care framework that should govern any medical intervention.

This is not just terminology. It is about whether products injected into billions of people are evaluated with the care their mechanism demands.

What Lessons Can We Draw?

What Should We Do?

Treat every new pathogen seriously. Especially non-natural ones. Early treatment is the only sustainable option Boost natural immunity Use reliable sources for prophylaxis & treatment Be responsible toward others if infected

Take Care of Your "Natural" Immunity

✓ Balanced diet ✓ Outdoor exercise (30 min/day, no mask) ✓ Quality sleep (away from screens) Daily supplementation if needed (Vit D, liposomal Vit C, Zinc). Especially over 65.

Prophylaxis

20+ molecules available without prescription (most also work for treatment) Reliable sources:

• c19early.org (prophylaxis tab)
• Dr. Sabatier
• Dr. Zelenko

Main prophylactics:

• Vitamin D
• Vitamin C
• Zinc
• Quercetin
• Curcumin
• Nigella sativa
• Ravintsara essential oil
• Aspirin
• Probiotics
• Ivermectin
• Doxycycline

Summary

Spike protein:

• Engineered through Gain of Function
• Contains HIV inserts for human infection
• Splits into neuroinflammatory (S1) and fusogenic (S2) components
• mRNA version has carcinogenic modifications
• Spike IS the biological weapon

mRNA injections:

• Make your body produce the toxic Spike protein
• mRNA Spike has unknown conformational changes
• No dose control
• No duration control
• No tissue specificity (thanks to LNPs)
• SV40 promoters enable nuclear entry and potential genome integration

Vaccine definition requires:

• Known antigen
• Known dose
• Prophylactic purpose

mRNA injections meet none of these criteria. They're genetic modification tools and biological weapons marketed as vaccines.

This article lays the biological foundation. For the manufacturing, contamination, and regulatory evidence that completes the case for halting these platforms, read: The Case for Halting mRNA Experiments.

Updated Evidence (2026)

Primary Research Papers Added:

• Stein et al., 2022 Nature: SARS-CoV-2 RNA/protein detected in basal ganglia up to 230 days post-infection [PMID: 36517603]
• UCSF Hellmuth et al., 2022: 59% of post-COVID patients met formal HAND diagnostic criteria
• Kempuraj et al., 2024: Spike protein stimulates microglia to release MMP-9, elevated in Long COVID [PMID: 39403255]
• Prenatal Spike Exposure, 2023: Gliosis, neuronal death in hippocampal CA1-CA3, autism-like neurobehavioral changes [PMID: 37889404]

Research Credit & Attribution:

This article is based on the presentation and research of Dr. Typhaine Pinsolle, with additional evidence integration from:

Original Research Contributors:

• Daniel B. Dugger – HIV Tat protein research and spike/Tat mechanistic parallels
• Dr. Annelise Bocquet – Spike protein innate immune system analysis
• Kevin McCairn, PhD – Amyloidogenic fibrin research

Gain-of-Function & Lab Origins Evidence:

• Steven E. Massey, Ph.D. – MERS chimera discovery in pre-pandemic Wuhan datasets
• Adrian Jones – Bioinformatics analysis linking MERS clone to Shi's pBAC-CMV system
• Yuri Deigin – Contributions to infectious clone attribution analysis
• Steven C. Quay, M.D., Ph.D. – MERS GoF research assessment
• @gadboit (X) – BsaI restriction sites bioinformatics analysis challenging Bruttel et al. claims
• Richard H. Ebright, Ph.D. – Expert confirmation of undeclared GoF experimentation

HIV Inserts Research:

• Pradhan et al., bioRxiv (2020) – "Uncanny similarity of unique inserts" (withdrawn preprint, DOI: 10.1101/2020.01.30.927871)
• Perez & Montagnier, Int J Res (2020) – Exogenous informative elements including HIV-related sequences
• Fantini et al., Int J Mol Sci (2023) – Structural/electrostatic similarities between SARS-CoV-2 spike and HIV-1 gp120

Spike Persistence & Quantification:

• Krauson et al., npj Vaccines (2023) – mRNA in lymph nodes/heart up to 30 days
• Ota et al. (2025) – Spike in cerebral arteries up to 17 months
• Patterson et al. (2025) – S1 in monocytes up to 245 days
• Zenodo case report (2026) – Spike detected at 1,173 days post-vaccination
• Stein et al., Nature (2022) – SARS-CoV-2 in basal ganglia up to 230 days (PMID: 36517603)

Government & Intelligence Sources:

• Senator Ron Johnson – HHS stroke signal document release (March 2026)
• German BND – Operation Saaremaa lab origin assessment (80-95% probability)
• NZZ (Neue Zürcher Zeitung) – Reporting on German intelligence assessment
• U.S. Right to Know – Baric email FOIA requests (~80,000 pages)
• Skopec R., J Vaccines Vaccin (2021) – Boyle bioweapon assessment summary

Origin Investigations & Data Integrity:

• Kevin McCairn, PhD – Huanan market data integrity analysis and NOASH recommendation documentation
• National Outbreak Analytics Steering Subcommittee (NOASH) – Pandemic origin investigation recommendations

Biological Weapons Law:

• Prof. Francis Boyle – U.S. Biological Weapons Anti-Terrorism Act architect (1989)
• Biological Weapons Convention (1975) – Articles I, III, IV text

Vaccine Safety Surveillance:

• VSD (Vaccine Safety Datalink) – HHS stroke signal detection 2022-2025
• VAERS (Vaccine Adverse Event Reporting System) – Adverse event clustering analysis

The author serves as a messenger conveying their research findings.

Follow Dr. Typhaine Pinsolle If you found this analysis valuable and want to support truth-tellers in medicine, follow Dr. Typhaine Pinsolle on X: https://x.com/PinsolleT

Based on the presentation "Once upon a time the Spike, the Covid and the biological weapons…" by Dr. Typhaine Pinsolle, August 15, 2024.